Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-20
1997-09-23
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 2302
Patent
active
056704771
ABSTRACT:
A method is provided to enhance the ability of a neurologically active compound to penetrate the blood nerve barrier (BNB) or blood brain barrier (BBB), by administration of a conjugate comprising the neurologically active compound linked to a carrier molecule that has been shown to have a substantial permeability coefficient across the BNB and BBB.
REFERENCES:
patent: 3903262 (1975-09-01), Pappenhagen et al.
patent: 4863730 (1989-09-01), Karpas
patent: 5260308 (1993-11-01), Poduslo et al.
Barnett et al., "Human.beta. Nerve Growth Factor Obtained from a Baculovirus Expression System has Potent in Vitro and in Vivo Neurotrophic Activity", Experimental Neurology, 110, 11-24, (1990).
Baskin et al., "Insulin in the Brain", Ann. Rev. Physiol., 49, 335-347, (1987).
F. Hefti et al., "Function of Neurotrophic Factors in the Adult and Aging Brain and Their Possible Use in the Treatment of Neurodegenerative Diseases", Neurobiology of Aging, 10, 515-533, (1989).
Franz Hefti, "Neurotrophic Factor Therapy for Nervous System Degenerative Diseases", Journal of Neurobiology, 25, 1418-1435, (1994).
Franz Hefti, "Development of Effective Therapy for Alzheimer's Disease Based on Neurotrophic Factors", Neurobiology of Aging, 15, S193-S194, (1994).
Joseph F. Poduslo et al., "Altered Blood-Nerve Barrier in Experimental Lead Neuropathy Assessed by Changes in Endoneurial Albumin Concentration", The Journal of Neuroscience, 2, 1507-1514, (Oct. 1982).
Joseph F. Poduslo, "Glycoprotein Molecular-Weight Estimation Using sodium dodecyl Sulfate-Pore Gradient Electrophoresis: Comparison of Tris-Glycine and Tris-Borate-EDTA Buffer Systems", Analytical Biochemistry, 114, 131-139, (1981).
Joseph F. Poduslo et al., "Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy", Proc. Natl. Acad. Sci. USA, 85, 4879-4883, (Jul. 1988).
Joseph F. Poduslo et al., "Macromolecular permeability across the blood-nerve and blood-brain barriers", Proc. Natl. Acad. Sci. USA, 91, 5705-5709, (Jun. 1994).
Emanuel Rechthand et al., "Regulation of the Microenvironment of Peripheral Nerve: role of the Blood-Nerve Barrier", Progress in Neurobiology, 28, 303-343 (1987).
Michael W. Schwartz et al., "Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid", Am. J. Physiol., 259, E378-E383, (1980).
Ananda Weerasuriya et al., "Blood-nerve transfer of albumin and its implications for the endoneurial microenvironment", Brain Research, 494, 114-121, (1989).
Chemical Abstracts AN 1989:190366, Koenig et al, 1989.
Curran Geoffrey L.
Poduslo Joseph F.
Curran Geoffrey L.
MacMillan Keith
Poduslo Joseph F.
LandOfFree
Method to enhance permeability of the blood/brain blood/nerve ba does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to enhance permeability of the blood/brain blood/nerve ba, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to enhance permeability of the blood/brain blood/nerve ba will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938642